A female Aedes mosquito, which spreads dengue virusNIAID
Bethesda, Maryland–(ENEWSPF)–March 17, 2016. A clinical trial in which volunteers were infected with dengue virus six months after receiving either an experimental dengue vaccine developed by scientists from the National Institutes of Health (NIH) or a placebo injection yielded starkly contrasting results. All 21 volunteers who received the vaccine, TV003, were protected from infection, while all 20 placebo recipients developed…